Telratolimod

DB19590InvestigationalSmall molecule

Telratolimod is a small molecule drug. The usage of the INN stem '-tolimod' in the name indicates that Telratolimod is a toll-like receptor (TLR) agonist. Telratolimod is under investigation in... Telratolimod is under investigation in clinical trial NCT06680479 (Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy).

Mechanism: Pharmacologically active on Toll-like receptor 7 and Toll-like receptor 8
Curator reviewed
Formula / weight: C₃₆H₅₉N₅O₂ · 593.901 g/mol (avg)
Code names: 3M-052 · 3M-052 AF · MEDI-9197

Resolves to

Compound

UNII16598XQ2BTCAS1359993-59-1ChEMBLCHEMBL4297631ChEBI757100PubChem56833311

Structure

InChIKeyRRTPWQXEERTRRK-UHFFFAOYSA-NSMILESCCCCCCCCCCCCCCCCCC(=O)NCCCCON1C(CCCC)=NC2=C1C1=C(C=CC=C1)N=C2N

Targets

Q9NYK1TLR7Q9NR97TLR8

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Telratolimod, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account